Rat mast cell protease-I enhances immunoglobulin E production by mouse B cells stimulated with interleukin-4

Immunology

Volumn 104, Issue 3, 2001, Pages 333-340

  Yoshikawa, Tsutomu ^a   Imada, Teruaki ^a   Nakakubo, Hiroshi ^a   Nakamura, Norifumi ^a   Naito, Koji ^a  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 [5 AMINO 2 (4 FLUOROPHENYL) 1,6 DIHYDRO 6 OXO 1 PYRIMIDINYL] N [1 [(5 METHOXYCARBONYL 2 BENZOXAZOLYL)CARBONYL] 2 PHENYLETHYL]ACETAMIDE; BENZYLSULFONYL FLUORIDE; CHYMASE; CHYMOSTATIN; ENZYME INHIBITOR; GI 129471; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G3; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; METALLOPROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG; ZINC ION;

ANIMAL CELL; ARTICLE; CELL LOSS; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PURIFICATION; FEMALE; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; INFLAMMATION; MACROPHAGE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEINASE INHIBITION; RAT; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; B-LYMPHOCYTES; CATTLE; CELL CULTURE TECHNIQUES; CHYMASES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MAST CELLS; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED BALB C; PHENYLALANINE; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERINE ENDOPEPTIDASES; SERINE PROTEINASE INHIBITORS; SPLEEN;

EID: 0035164012     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2001.01320.x     Document Type: Article

References (54)

1. Mast cell proteases: A historical perspective
2. Role of mast cells and basophils in asthma
3. Chymase: Its pathophysiological roles and inhibitors
4. Activation of rat serosal mast cells by chymase, an endogenous secretory granule protease
5. Mast cell chymase: A potent secretagogue for airway gland serous cells
6. Regulation of IgE synthesis
7. Modulation of the biologic activities of IgE-binding factor. IV. Identification of glycosylation-enhancing factor as a kallikrein-like enzyme
8. Purification of murine suppressive factor of allergy into distinct CD23-modulating and IgE-suppressive proteins
9. The murine ε receptor modulating protein: A novel serine protease which modulates CD23 binding to IgE
10. εRMP: A novel serine protease expressed on activated T-cell membranes enhanced IL-4-induced IgE synthesis by B cells
11. Biphasic effect of kallikrein on IgE and IgG1 syntheses by LPS/IL-4-stimulated B cells
12. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart
13. Synthesis, structure-activity relationships and pharmacokinetic profiles of non-peptidic α-keto heterocycles as novel inhibitors of human chymase
14. Recombinant soluble form of the human high-affinity receptor for IgE prevents anaphylactic shock in mice
15. Prostaglandin E2 promotes B lymphocytes Ig isotype switching to IgE
16. Secretory granule proteases in rat mast cells. Cloning of 10 different serine proteases and a carboxypeptidase A from various rat mast cell populations
17. Selective inhibition of antigen presentation to cloned T cells by protease inhibitors
18. 84 bond by mast cell chymase
19. Mast cell proteinases activate precursor forms of collagenase and stromelysin, but not of gelatinases A and B
20. Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II
21. Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain
22. IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (Fc epsilon RII)
23. Inhibition of sCD23 and immunoglobulin E release from human B cells by a metalloproteinase inhibitor, GI 129471
24. Regulation of tumor necrosis factor-alpha processing by a metalloproteinase inhibitor
25. Two types of human mast cells that have distinct neutral protease compositions
26. Chymotrypsin-like proteinases of human skin mast cells
27. Induction of vascular permeability enhancement by human tryptase: Dependence on activation of prekallikrein and direct release of bradykinin from kininogens
28. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro
29. Tryptase-chymase doublepositive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines
30. Effect of recombinant human IL-4 on tryptase, chymase, and Fce receptor type I expression in recombinant human stem cell factor-dependent fetal liver-derived human mast cells
31. Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation
32. Induction of the high-affinity IgE receptor (Fc epsilon RI) on human mast cells by IL-4
33. IgE enhanced mouse mast cell Fc (epsilon) RI expression in vitro and in vivo: Evidence for a novel amplification mechanism in IgE-dependent reactions
34. Mast cell Fc epsilon RI expression in the rat intestinal mucosa and tongue is enhanced during Nippostrongylus brasiliensis infection and can be up-regulated by in vivo administration of IgE
35. IgE enhanced Fc epsilon receptor I expression and IgE-dependent release of histamine and lipid mediators from human umbilical cord blood-derived mast cells: Synergistic effect of IL-4 and IgE on human mast cell Fc epsilon receptor I expression and mediator release
36. Induction of human IgE synthesis in B cells by mast cells and basophils
37. Multiple cytokine mRNA expression in human mast cells stimulated via Fc epsilon RI
38. Activated mast cells produce interleukin 13
39. Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: Enhanced IL-13 production by IL-4-primed human mast cells
40. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the FceRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells
41. Localization of IgE to lung germinal lymphoid follicles in a patient with allergic bronchopulmonary aspergillosis
42. The physiology ofmurinegerminal centerreactions
43. Histamine selectively enhances human immunoglobulin E (IgE) and IgG4 production induced by anti-CD58 monoclonal antibody
44. Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes
45. Stimulation of human lymphocytes by cathepsin G
46. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemo-attractants for mononuclear cells and neutrophils
47. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: More similarities than differences
48. Association between genetic variants of mast-cell chymase and eczema
49. Association between variants of mast cell chymase gene and serum IgE levels in eczema
50. Association between mast cell chymase genotype and atopic eczema: Comparison between patients with atopic eczema alone and those with atopic eczema and atopic respiratory disease
51. What are human heart mast cells for?
52. Chymase-dependent angiotensin II formation in human vascular tissue
53. Molecular and cellular biology of mast cells and basophils
54. Mercuric chloride-treated Brown Norway rats develop widespread tissue injury including necrotizing vasculitis